Published in J Gen Microbiol on March 01, 1983
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun (1996) 1.98
Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.84
A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1996) 1.33
A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol (2000) 1.26
Role of cord factor in the modulation of infection caused by mycobacteria. Am J Pathol (1985) 1.19
Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun (2004) 0.97
Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria. Infect Immun (1988) 0.94
Characterization of Mycolic Acids in Total Fatty Acid Methyl Ester Fractions from Mycobacterium Species by High Resolution MALDI-TOFMS. Mass Spectrom (Tokyo) (2015) 0.76
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol (1995) 15.19
Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis (1995) 6.95
Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother (1994) 5.64
Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet (1993) 5.52
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol (1997) 5.28
Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol (1998) 4.83
Insects in the transmission of Mycobacterium ulcerans infection. Lancet (1999) 4.46
Numerical classification of Streptomyces and related genera. J Gen Microbiol (1983) 3.97
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis (1995) 3.83
Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol (1992) 3.65
Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother (1997) 3.55
Ecology of actinomycetes. Annu Rev Microbiol (1983) 3.39
Identification of Mycobacterium species by using amplified ribosomal DNA restriction analysis. J Clin Microbiol (1993) 3.38
Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med (1995) 3.09
Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis (1999) 3.08
Mycolic acid patterns of some species of Mycobacterium. Arch Microbiol (1984) 3.02
DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet (1989) 2.91
Lipid composition in the classification and identification of acid-fast bacteria. Soc Appl Bacteriol Symp Ser (1980) 2.82
A phylogenetic analysis of the genus Nocardia with 16S rRNA gene sequences. Int J Syst Bacteriol (1995) 2.76
The actinomycete-genus Rhodococcus: a home for the "rhodochrous" complex. J Gen Microbiol (1977) 2.75
Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis (2000) 2.71
Differentiation of Mycobacterium, Nocardia, and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. J Gen Microbiol (1975) 2.70
Search and discovery strategies for biotechnology: the paradigm shift. Microbiol Mol Biol Rev (2000) 2.64
IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol (1991) 2.64
Numerical taxonomy of some nocardioform bacteria. J Gen Microbiol (1971) 2.63
A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans. J Clin Microbiol (2000) 2.43
Distribution of menaquinones in actinomycetes and corynebacteria. J Gen Microbiol (1977) 2.28
Geographically distinct isolates of Mycobacterium leprae exhibit no genotypic diversity by restriction fragment-length polymorphism analysis. Mol Microbiol (1990) 2.25
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis (2004) 2.20
Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J Clin Microbiol (1992) 2.18
A numerical classification of the genus Bacillus. J Gen Microbiol (1988) 2.14
Biodiversity as a source of innovation in biotechnology. Annu Rev Microbiol (1992) 2.11
Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh. Int J Tuberc Lung Dis (2004) 2.08
Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis (2000) 2.01
Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1995) 1.94
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem (2000) 1.92
Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol (2001) 1.85
Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol (2001) 1.85
Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol (1998) 1.85
Comparison of two PCRs for detection of Mycobacterium ulcerans. J Clin Microbiol (1999) 1.82
Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis (2001) 1.75
[Epidemiology of ulcers due to Mycobacterium ulcerans]. Ann Soc Belg Med Trop (1989) 1.74
Nocardia africana sp. nov., a new pathogen isolated from patients with pulmonary infections. J Clin Microbiol (2001) 1.73
A taxonomic study of Gardnerella vaginalis (Haemophilus vaginalis) Gardner and Dukes 1955. J Gen Microbiol (1980) 1.69
Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.69
Mycolic acid patterns of representative strains of Mycobacterium fortuitum, 'Myobacterium peregrinum' and Mycobacterium smegmatis. J Gen Microbiol (1984) 1.67
Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans. J Clin Microbiol (2002) 1.67
Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. Br J Dermatol (1996) 1.67
A survey of the structures of mycolic acids in Corynebacterium and related taxa. J Gen Microbiol (1982) 1.64
Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis (1999) 1.63
[Buruli ulcer: risk of bone involvement! Apropos of 33 cases observed in Benin]. Med Trop (Mars) (2000) 1.63
Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis (2007) 1.62
Free mycolic acids as criteria in the classification of Nocardia and the 'rhodochrous' complex. J Gen Microbiol (1976) 1.59
Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay. Eur J Clin Microbiol Infect Dis (1999) 1.59
Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J Gen Microbiol (1974) 1.58
The use of IS2404 restriction fragment length polymorphisms suggests the diversity of Mycobacterium ulcerans from different geographical areas. Am J Trop Med Hyg (2001) 1.54
Mycobacterium elephantis sp. nov., a rapidly growing non-chromogenic Mycobacterium isolated from an elephant. Int J Syst Evol Microbiol (2000) 1.54
Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases. Int J Tuberc Lung Dis (2001) 1.53
Numerical classification of some named strains of Nocardia asteroides and related isolates from soil. J Gen Microbiol (1980) 1.51
In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. J Antimicrob Chemother (2000) 1.50
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. Infect Immun (2001) 1.50
Expression of a borage desaturase cDNA containing an N-terminal cytochrome b5 domain results in the accumulation of high levels of delta6-desaturated fatty acids in transgenic tobacco. Proc Natl Acad Sci U S A (1997) 1.49
Studies on the mycolic acids from the walls of Mycobacterium microti. J Gen Microbiol (1982) 1.49
Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum. J Clin Microbiol (2001) 1.49
Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health (2004) 1.48
Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol (1994) 1.47
A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area. Int J Syst Bacteriol (1995) 1.45
[Mycobacterium ulcerans cutaneous infections: Buruli ulcers]. Med Trop (Mars) (1995) 1.44
Amycolatopsis methanolica sp. nov., a facultatively methylotrophic actinomycete. Int J Syst Bacteriol (1990) 1.44
Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis (2005) 1.43
Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother (2001) 1.40
Studies on Mycobacterium chelonei. J Med Microbiol (1972) 1.40
Fatty and mycolic acids of Mycobacterium malmoense. J Clin Microbiol (1988) 1.40
Fatty acid composition of some mycolic acid-containing coryneform bacteria. J Gen Microbiol (1982) 1.40
The mycolic acids of Mycobacterium chelonei. J Gen Microbiol (1982) 1.39
Further studies on African strains of Mycobacterium tuberculosis: comparison with M. bovis and M. microti. Ann Soc Belges Med Trop Parasitol Mycol (1970) 1.38
Rhodococcus equi infection in 3 AIDS patients. Acta Clin Belg (1996) 1.38
A probability matrix for identification of some Streptomycetes. J Gen Microbiol (1983) 1.38
Mycobacterium novocastrense sp. nov., a rapidly growing photochromogenic mycobacterium. Int J Syst Bacteriol (1997) 1.36
Aerobic mineralization of trichloroethylene, vinyl chloride, and aromatic compounds by rhodococcus species. Appl Environ Microbiol (1994) 1.35
Phylogenetic study of the species within the family Streptomycetaceae. Antonie Van Leeuwenhoek (2011) 1.34
Mycobacterium cookii sp. nov. Int J Syst Bacteriol (1990) 1.34
Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis (1998) 1.32
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob Agents Chemother (1999) 1.30
Comparison of phenotypic and genotypic methods for detection of diphtheria toxin among isolates of pathogenic corynebacteria. J Clin Microbiol (1998) 1.30
Replacement of acidic phosphates by acidic glycolipids in Pseudomonas diminuta. Nature (1974) 1.29
First molecular epidemiological study of tuberculosis in Benin. Int J Tuberc Lung Dis (2009) 1.28
Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin. Int J Tuberc Lung Dis (2007) 1.27